-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomes: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation